| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |